-
-
Call more information
660-596-2224 -
Author: Michael Vlessides Anesthesiology News There is now a tool to help predict which patients are at greatest risk for unplanned readmission after ambulatory surgery. “Readmission is often regarded as a measure of poor perioperative patient care and can also be a significant economic burden for both hospitals and patients,” said Maria PatrocÍnio, MD, a […]
Read MorePregabalin does not appear to be effective for controlling pain in patients with chronic post-traumatic peripheral neuropathic pain (PTNP), according to a study published in the Journal of Neurology. Pregabalin, an alpha2-delta ligand, is approved in the US for the treatment of neuropathic pain associated with diabetic peripheral neuropathy and spinal cord injury, and for postherpetic neuralgia. […]
Read MoreAuthors: Albrecht E et al Anesth Analg. 2018 Oct BACKGROUND: Both dexamethasone and dexmedetomidine are effective peripheral nerve block (PNB) perineural adjuncts that prolong block duration. However, each is associated with side effects. With paucity of head-to-head comparisons of these adjuncts, the question of the best adjunct to mix with local anesthetics (LA) for PNB is unanswered. This meta-analysis aims to inform current practice and future research by […]
Read MoreWhile people who are morbidly obese are more likely to undergo moderately difficult intubation, they do not have an increased rate of severely difficult intubation, according to a study presented here at the 2018 Annual Meeting of the American Society of Anesthesiologists (ASA). “Morbidly obese patients have changes in their anatomy and pulmonary physiology that […]
Read MorePatients undergoing robotic hysterectomy were found to report comparable pain scores when receiving celecoxib perioperatively or ketorolac postoperatively — both as part of a multimodal pain management plan — in a study published in Gynecologic Oncology. In addition, treatment that included celecoxib was associated with lower postoperative opioid use. Celecoxib, a COX-2 inhibitor with anti-inflammatory properties, is not […]
Read More